Search

everythinglearnresearchcommunity

for

Search:↓

α-MSH and cyclic AMP boost melanin production, while cyclic GMP and melatonin reduce it.

Targeted cancer therapies often cause skin problems that need careful management to improve patient quality of life and treatment success.

The document concludes that DAB389-IL2 is promising for treating refractory cutaneous T-cell lymphoma, but more research is needed on its effectiveness and side effect management.

Some patients on immune therapy for melanoma may develop scarring hair loss, but cancer treatment remains effective.

Blocking casein kinase 1 in skin cells can help melanocyte precursors move better, potentially helping with conditions like vitiligo or gray hair.

High-dose methotrexate can cause severe skin and nail issues.

Monocyte-derived dendritic cells play a key role in UVB-induced skin sensitivity and inflammation.

Stopping mitochondrial respiration can prevent brain cancer spread in skin cancer patients, and plant compound β-sitosterol could help achieve this.

Patients with melanoma who saw dermatologists and were from higher-income areas were more likely to have follow-up visits, which was linked to lower mortality.

Increased pigmentation may protect skin from UVB, new targets for skin disease treatments were identified, sunscreen ingredients don't affect hormones, TNF-α inhibitors may help diabetic wounds, and certain treatments could prevent chemotherapy-induced hair loss.

α-MSH may help treat skin inflammation and fibrosis.

Finasteride reduces melanin production, possibly treating hyperpigmentation and melanoma, but needs more safety research.

Different melanocyte types in hair follicles either survive or die during the catagen phase.

Tocilizumab therapy may cause skin and hair conditions like halo naevi, vitiligo, and alopecia areata.

Bendamustine combined with tucidinostat may effectively treat adult T-cell leukemia.

The document concludes that the immune-inhibitory environment of the hair follicle may prevent melanoma development.

Activating c-Myc in skin causes rapid cell growth and changes, but these effects are reversible.

Human melanocytes have unique traits that affect melanoma development and prognosis.

Asiasari radix extract may be a potential treatment for melanoma because it selectively triggers cell death in melanoma cells by affecting p53 regulation.

Photodynamic therapy improved skin issues from sorafenib when other treatments failed.

ATP increases melanin production in skin after UV exposure, with the P2X7 receptor being crucial for this process.

Pimecrolimus boosts melanin production and movement of skin pigment cells.

Decreasing MIG6 can increase the movement and invasiveness of MEK-inhibited mutant NRAS melanoma, particularly when stimulated by EGF.

Dynlt3 is important for melanosome transport and skin coloration.

High S100B protein levels indicate poor survival in advanced melanoma.

Alkylating agents can kill cancer cells but may cause skin and allergic reactions.

Exosomes from Pinctada martensii mucus can safely reduce melanin production, offering a new treatment for skin pigment issues.

Melanocytes are important for skin and hair color and protect the skin from UV damage.

An automated system can predict death risk in thin melanoma by analyzing immune cells.